CYP19A1 and obesity disorder: This finding is consistent with a research conducted in Baghdad in 2016 on T2DM males between the ages of 37 and 66 years old, which found that elevated E2 levels in T2DM were caused by the enzyme aromatase, which is related to obesity, and associated with T2DM [22].